TY  - JOUR
AU  - Lozano-Rodríguez, Roberto
AU  - Valentín-Quiroga, Jaime
AU  - Avendaño-Ortiz, José
AU  - Martín-Quirós, Alejandro
AU  - Pascual-Iglesias, Alejandro
AU  - Terrón-Arcos, Verónica
AU  - Montalbán-Hernández, Karla
AU  - Casalvilla-Dueñas, José Carlos
AU  - Bergón-Gutiérrez, Marta
AU  - Alcamí, José
AU  - García-Pérez, Javier
AU  - Cascajero Díaz, Almudena
AU  - García-Garrido, Miguel Ángel
AU  - Balzo-Castillo, Álvaro Del
AU  - Peinado, María
AU  - Gómez, Laura
AU  - Llorente-Fernández, Irene
AU  - Martín-Miguel, Gema
AU  - Herrero-Benito, Carmen
AU  - Benito, José Miguel
AU  - Rallón, Norma
AU  - Vela-Olmo, Carmen
AU  - López-Morejón, Lissette
AU  - Cubillos-Zapata, Carolina
AU  - Aguirre, Luis A
AU  - Fresno, Carlos Del
AU  - López-Collazo, Eduardo
PY  - 2022
DO  - 10.1016/j.celrep.2021.110235
UR  - http://hdl.handle.net/20.500.12105/14394
AB  - We have analyzed BNT162b2 vaccine-induced immune responses in naive subjects and individuals recovered from coronavirus disease 2019 (COVID-19), both soon after (14 days) and later after (almost 8 months) vaccination. Plasma spike (S)-specific...
LA  - eng
PB  - Cell Press
KW  - BNT162b2 vaccine
KW  - COVID-19-recovered
KW  - SARS-CoV-2
KW  - Antigen-specific T cell
KW  - Cellular responses
KW  - Cytokine production
KW  - Humoral responses
KW  - Memory B cell
KW  - Proliferation
KW  - Spike
TI  - Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19
TY  - journal article
ER  -